What is the Central Nervous System Treatment Market Reaching a Value of USD 232.41 Billion by 2035?
The Central Nervous System Treatment Market encompasses pharmaceutical drugs, biologics, and advanced therapeutics used to diagnose, manage, and treat disorders affecting the brain and spinal cord. These disorders include neurodegenerative diseases, neurovascular conditions, mental health disorders, infectious diseases of the CNS, and other complex neurological conditions. The market has gained critical importance due to the rising global burden of neurological and mental health disorders, aging populations, and increasing exposure to lifestyle-related risk factors. Conditions such as Alzheimer’s disease, Parkinson’s disease, stroke, epilepsy, anxiety, and mood disorders now represent some of the leading causes of disability worldwide. In 2025, the central nervous system treatment market was valued at USD 128.56 Billion . Supported by innovation in drug development, biologics, and precision medicine, the market is expected to grow at a CAGR of 6.10% between 2026 and 2035 , reach...